LivaNova (LIVN) Cash from Operations (2015 - 2026)
LivaNova (LIVN) posted Cash from Operations of 15216000.0 for Q1 2026, down 81.53% sequentially from 82397000.0 in Q4 2025, and down 36.51% YoY from 23966000.0 in Q1 2025.
LivaNova (LIVN) Cash from Operations (2015 - 2026) Analysis & Trends
LivaNova has reported Cash from Operations for 12 years, with the latest figure at 15216000.0 in Q1 2026.
- Quarterly Cash from Operations fell 36.51% year-over-year to 15216000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 245590000.0 (up 24.65% YoY) and the FY2025 annual result came in at 254340000.0, up 38.95% from the prior year.
- Cash from Operations eased to 15216000.0 in Q1 2026 per LIVN's latest filing, from 82397000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 85057000.0 in Q3 2025 and troughed at 17937000.0 in Q2 2023.
- A 5-year average of 35142882.35 and a median of 25823000.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations tumbled 139.96% in 2022, then surged 341.71% in 2024.
- Over 5 years, Cash from Operations stood at 18703000.0 in 2022, then jumped by 188.5% to 53958000.0 in 2023, then surged by 45.87% to 78707000.0 in 2024, then increased by 4.69% to 82397000.0 in 2025, then tumbled by 81.53% to 15216000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 15216000.0, 82397000.0, and 85057000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 127.82 Bn | 124.35 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 118.80 Bn | 109.58 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 73.38 Bn | 72.84 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.44 Bn | 32.50 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.80 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn | 367.10 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 66.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.59 Mn |
| Jun 30, 2026 | 66.59 Mn |
| Mar 31, 2026 | 15.22 Mn |
| Mar 31, 2026 | 15.22 Mn |
| Dec 31, 2025 | 82.40 Mn |
| Dec 31, 2025 | 82.40 Mn |
| Sep 30, 2025 | 85.06 Mn |
| Sep 30, 2025 | 85.06 Mn |
| Jun 30, 2025 | 62.92 Mn |
| Jun 30, 2025 | 62.92 Mn |
| Mar 31, 2025 | 23.97 Mn |
| Mar 31, 2025 | 23.97 Mn |
| Dec 31, 2024 | 78.71 Mn |
| Dec 31, 2024 | 78.71 Mn |
| Sep 30, 2024 | 50.99 Mn |
| Sep 30, 2024 | 50.99 Mn |
| Jun 30, 2024 | 43.36 Mn |
| Jun 30, 2024 | 43.36 Mn |
| Mar 31, 2024 | 9.98 Mn |
| Mar 31, 2024 | 9.98 Mn |